Ultrafiltration Therapy for Cardiorenal Syndrome: Physiologic Basis and Contemporary Options

Publisher： Karger

E-ISSN： 1421-9735|34|2|149-157

ISSN： 0253-5068

Source： Blood Purification, Vol.34, Iss.2, 2012-10, pp. : 149-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cardiorenal Syndrome: Basis and Common Ground for a Multidisciplinary Patient-Oriented Therapy

By  

Cardiorenal Medicine, Vol. 1, Iss. 1, 2011-01 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

The Cardiorenal Syndrome

By  

Blood Purification, Vol. 27, Iss. 1, 2009-01 ,pp. : 114-126

Karger

Access to resources Recommend Favorite

Prognostic Factors in Continuous Hemofiltration Therapy for Patients with Cardiorenal Syndrome

By  

Blood Purification, Vol. 37, Iss. 2, 2014-02 ,pp. : 99-105

Karger

Access to resources Recommend Favorite

Effect of Ultrafiltration versus Intravenous Furosemide for Decompensated Heart Failure in Cardiorenal Syndrome: A Systematic Review with Meta-Analysis of Randomized Controlled Trials

By  

Nephron, Vol. 129, Iss. 3, 2015-02 ,pp. : 189-196

Karger

Access to resources Recommend Favorite

Biomarkers in Cardiorenal Syndrome

By  

Blood Purification, Vol. 37, Iss. 2, 2014-07 ,pp. : 14-19

Karger

Access to resources Recommend Favorite